Akari Therapeutics Plc Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q2 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Akari Therapeutics Plc quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q2 2023 to Q2 2024.
  • Akari Therapeutics Plc Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending June 30, 2024 was $0.000.
  • Akari Therapeutics Plc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $368K, a 39.5% decline from 2022.
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 $0 Apr 1, 2024 Jun 30, 2024 8-K 2024-09-06
Q2 2023 $0 Apr 1, 2023 Jun 30, 2023 8-K 2024-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.